Middle East & Africa Implantable Cardioverter Defibrillators Market Size & Outlook
Related Markets
MEA implantable cardioverter defibrillators market highlights
- The MEA implantable cardioverter defibrillators market generated a revenue of USD 139.5 million in 2023.
- The market is expected to grow at a CAGR of 4.3% from 2024 to 2030.
- In terms of segment, transvenous implantable cardioverter-defibrillators was the largest revenue generating product in 2023.
- Subcutaneous Implantable Cardioverter Defibrillators is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 139.5 million |
| Market revenue in 2030 | USD 187.6 million |
| Growth rate | 4.3% (CAGR from 2023 to 2030) |
| Largest segment | Transvenous implantable cardioverter-defibrillators |
| Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.7% of the global implantable cardioverter defibrillators market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,236.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Implantable Cardioverter Defibrillators Market Scope
Implantable Cardioverter Defibrillators Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| MicroPort Scientific Corp | View profile | 8230 | 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, China, People's Republic of, 201203 | https://www.microport.com |
| BIOTRONIK | View profile | 5001-10000 | Berlin, Berlin, Germany, Europe | https://www.biotronik.com/de-de |
| LivaNova PLC | View profile | 2900 | 20 Eastbourne Terrace, London, United Kingdom, W2 6LG | https://www.livanova.com |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
Middle East & Africa implantable cardioverter defibrillators market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 89.32% in 2023. Horizon Databook has segmented the Middle East & Africa implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
The ICD market in the MEA is growing rapidly due to the high prevalence of cardiac diseases. With more people suffering from cardiovascular conditions, the demand for effective monitoring and treatment options like ICDs is growing rapidly.
Moreover, increased Research and Development (R&D) expenditure in the region is supported by government funding. For instance, in 2020, the UAE allocated 1.3% of its GDP to R&D, and the Abu Dhabi Government invested USD 1.09 billion in healthcare R&D.
This investment fosters innovation and advancements in medical technologies, including ICD devices. The significant funding of USD 10.89 million for 53 research projects in 2021 across various sectors also shows the commitment of MEA governments to advance medical technologies. These efforts are expected to further drive growth in the MEA ICD market.
Reasons to subscribe to Middle East & Africa implantable cardioverter defibrillators market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa implantable cardioverter defibrillators market databook
-
Our clientele includes a mix of implantable cardioverter defibrillators market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa implantable cardioverter defibrillators market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA implantable cardioverter defibrillators market size, by country, 2018-2030 (US$M)
Middle East & Africa Implantable Cardioverter Defibrillators Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
